(Q46689242)

24 December 2017

title

Sustained improvement of clinical outcome with risperidone long-acting injectable in psychotic patients previously treated with olanzapine (English)

1 reference

24 December 2017

1 reference

1 reference

M Gastpar

1

1 reference

24 December 2017

M Masiak

2

1 reference

24 December 2017

M A Latif

3

1 reference

24 December 2017

S Frazzingaro

4

1 reference

24 December 2017

R Medori

5

1 reference

24 December 2017

E-R Lombertie

6

1 reference

24 December 2017

language of work or name

English

0 references

publication date

1 September 2005

1 reference

24 December 2017

Journal of Psychopharmacology

published in

1 reference

24 December 2017

volume

19

1 reference

24 December 2017

issue

5 Suppl

1 reference

24 December 2017

page(s)

32-38

1 reference

24 December 2017

Antipsychotic medication adherence: is there a difference between typical and atypical agents?

cites work

1 reference

https://api.crossref.org/works/10.1177%2F0269881105056598

Treatment of negative and cognitive symptoms

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881105056598

Long-acting injectable risperidone: efficacy and safety of the first long-acting atypical antipsychotic

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881105056598

The positive and negative syndrome scale (PANSS) for schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881105056598

Efficacy and safety of long-acting risperidone in stable patients with schizoaffective disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881105056598

Patients with schizophrenia previously stabilized on conventional depot antipsychotics experience significant clinical improvements following treatment with long-acting risperidone

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881105056598

Long-acting risperidone vs. placebo in the treatment of hospital inpatients with schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881105056598

Efficacy and safety of direct transition to risperidone long-acting injectable in patients treated with various antipsychotic therapies

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881105056598

Tolerability of atypical antipsychotics

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881105056598

Improvements in stable patients with psychotic disorders switched from oral conventional antipsychotics therapy to long-acting risperidone

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881105056598

21 January 2018

Identifiers

DOI

10.1177/0269881105056598

1 reference

24 December 2017

1 reference

24 December 2017